Rifampicin inhibition of vaccinia virus in mice
Mückter, H.; Sous, H.; Poszich, G.; Nijssen, J.
Arzneimittel-Forschung 21(10): 1571-1572
1971
ISSN/ISBN: 0004-4172 PMID: 5171889 Document Number: 38776
Document emailed within 1 workday
Related Documents
Topa, P.K.; Rao, K.V. 1976: Extraction of vaccinia virus and purification of vaccinia elementary body suspension with Mafron 11 Indian Journal of Medical Research 64(10): 1421-1431Prasad, C.B.; Hedström, K.G. 1974: Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 148(2): 97-111
Zgórniak-Nowosielska, I.; Cwiek, D.; Sławińska, B. 1985: Immune response in vaccinia virus infected mice treated with N,N'-bis/methylisatin-beta-thiosemicarbazone/-2-methylpiperazine Archivum Immunologiae et Therapiae Experimentalis 33(6): 769-776
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Sehgal, C.L.; Murty, D.K.; Vijayan, P.; Suri, N.K.; Raghavan, N.G. 1973: Studies on different strains of vaccinia virus with particular reference to their quality regarding immunogenicity and reactogenicity. I. Studies in embryonated eggs, mice and thermostability Indian Journal of Medical Research 61(3): 361-370
Haishi, S.; Imai, H.; Hirai, K.; Igarashi, A.; Kato, S. 1989: Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus Acta Virologica 33(6): 497-503
Sitnikov, B.S.; Gendon, I.Z. 1970: "Rescue" of the rct40 plus-marker of vaccinia virus in different methods of inactivation of the donor virus Voprosy Virusologii 15(3): 278-283
Knyszynski, A.; Gottlieb, P.; Fridkin, M. 1983: Inhibition by tuftsin of Rauscher virus leukemia development in mice Journal of the National Cancer Institute 71(1): 87-90
Wojcik, J. 1995: Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector Acta Microbiologica Polonica 44(2): 191-196
Sottnek, H.M.; Cassel, W.A.; Campbell, W.G. 1975: The pathogenesis of Vaccinia virus toxicity. I. the role of virus-platelet interaction Laboratory Investigation; a Journal of Technical Methods and Pathology 33(5): 514-521
Sviatchenko, V.A.; Agapov, E.V.; Urmanov, I.Kh.; Serpinskiĭ, O.I.; Frolov, I.V.; Kolykhalov, A.A.; Ryzhikov, A.B.; Netesov, S.V. 1993: The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus Voprosy Virusologii 38(5): 222-226
Bruckner, S.; Ciugarin, M.; Cotarcea, S.; Istodor, N. 1972: Double infection with vaccinia virus and echo virus Annales de Pediatrie 19(3): 253-255
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990
Pusateri, A.M.; Ewalt, L.C.; Lodmell, D.L. 1980: Nonspecific inhibition of encephalomyocarditis virus replication by a type Ii interferon released from unstimulated cells of Mycobacterium tuberculosis-sensitized mice Journal of Immunology 124(3): 1277-1283
Beaud, G.; Mars, M.; Vassef, A. 1987: Vaccinia virus as a vector Developments in Biological Standardization 66: 49-54
Smithwick, E.M.; Steiner, M.; Quick, J.D. 1972: Vaccinia virus and tuberculin reactivity Pediatrics 50(4): 660-661
Ghendon, Y.Z.; Rozina, E.E.; Marchenko, A.T. 1973: On the "neuropathogenicity" mechanism of vaccinia virus Acta Virologica 17(2): 169
Korbecki, M.; Bankowski, A.; Filczak, K.; Klimek, A. 1985: Dipyridamole as an inhibitor of vaccinia virus replication Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1: 29-32